CareHub™ Value Proposition
Idea + Community + Technology = Solution
Hospital EHR + Pharma RWE + Solo Practitioners
Automated Weekly Expansion via i18next
8 Chronic Conditions Worldwide
I. The Care Gap
Treatment Decisions Based on Memory
Cancer patients see their doctor every 3-4 months. The physician asks "How have you been?" and makes critical treatment decisions based on what the patient remembers from 90+ days. No continuous vitals. No side effect trends. No medication adherence data.
Mental Health Left Behind
280 million people live with depression. Physical symptoms in one system, mental health in another. Oncologists don't see depression scores. Psychiatrists don't see cancer vitals. The patient falls through the gap.
Language Barriers Kill
Limited English proficiency patients face 2-3x higher mortality rates. Misunderstood treatment instructions. Medication errors. 9 out of 10 health apps don't support their language.
The Solution
Free patient app tracks daily vitals across 8 chronic conditions in 116 languages. Physicians get real-time access through ProviderConnect. Episodic care becomes continuous monitoring.
All data sharing subject to patient or authorized caregiver consent.
II. ProviderConnect™: The Solution
What Patients Track
Daily vitals through our Tracking Calendar: blood pressure, mental health (PHQ-9), side effects, nutrition, pain levels, hydration, GI function, medication adherence, weight, sleep quality. Rolling 90-day analysis identifies patterns invisible to quarterly appointments.
What Physicians See
ProviderConnect™ gives physicians continuous access. Review 90 days of vitals in seconds. Spot concerning trends before emergencies. Adjust medications proactively when side effects emerge. Make evidence-based decisions instead of educated guesses.
Integrated Mental Health
Mental health and physical health tracked together. Depression worsens cancer outcomes by 20-30%. Anxiety reduces treatment adherence. Social isolation increases mortality by 29%. We catch these patterns early.
Reactive → Proactive
- Before: "Your cancer spread because we didn't catch warning signs 2 months ago"
- After: "Your vitals show early kidney stress from chemo-let's adjust dosage before damage occurs"
All data sharing subject to patient or authorized caregiver consent.
III. Revenue Model
Three Revenue Streams
Enterprise Subscriptions ($15/patient/month): Hospitals reduce readmissions, improve HCAHPS scores, capture CMS quality bonuses. CMS reimburses $19-61/patient/month for remote monitoring-our pricing is 75%+ below their cost.
Pharmaceutical RWE Licensing: Post-market surveillance tracking 10,000+ patients in real-world conditions. Track efficacy across demographics, catch side effects missed in trials, optimize dosing. Better data prevents billion-dollar recalls and accelerates FDA approvals.
Solo Practitioner Subscriptions ($1/patient/month): Patient-driven demand. "My patient uses CareHub, I need access." Lower volume, higher loyalty.
5-Year Projection
| Year | Disease Modules | EHR Patients | Total ARR |
|---|---|---|---|
| 2026 | Cancer (pilot) | 40-80K | $4-8M |
| 2027 | + Alzheimer's, Autism | 250K | $30M |
| 2028 | + Parkinson's, Diabetes | 1M | $115M |
| 2029 | + Obesity, Long COVID | 3M | $350M |
| 2030 | All 8 (mature) | 7M | $830M |
IPO Target: ~$8.3B (2030)
- $830M+ ARR at 10x SaaS revenue multiple
- 7M EHR patients across 8 chronic conditions
- 116 languages with automated expansion
- Patient app stays free forever-enterprise revenue funds everything
IV. What Makes Us Different
One Token Across 8 Conditions
Most health apps focus on one disease. We use one token across all conditions: Cancer, Alzheimer's, Autism, Parkinson's, Long COVID, Obesity, Type II Diabetes, Aged Care. Network effects compound. Cancer patients trading with Alzheimer's caregivers creates liquidity monopoly. Competitors would need to launch for all 8 conditions at once.
116 Languages Now
Most apps launch in 2-3 languages and call it "global." We support 116 locales with automated weekly expansion via i18next. Cross-disease progression data in Mandarin, Arabic, Navajo worth billions to pharma. Competitors are years behind.
Cultural Ambassadors
9 strategic community leaders opening doors in markets competitors can't access: tribal lands, favelas, rural Africa, immigrant communities. Trusted entry where traditional marketing fails. Replicating this network takes years.
Why Now
Long COVID created 400 million people who need long-term health tracking. Telehealth normalized during the pandemic. AI finally enables personalized insights at scale. The infrastructure exists. The market is ready. Competitors are still building single-disease apps. By the time they realize one platform across 8 conditions creates network effects, we'll have 2+ years of patient data they can't replicate.
Winner-Take-Most Dynamics
- Cross-disease insights: Tracking cancer→Alzheimer's risk, obesity→mental health-pharmaceutical licensing gold
- Multilingual data monopoly: Only platform capturing progression data in 116 languages across 8 conditions
- Geographic barriers: First-mover advantage in underserved markets competitors can't enter
- Patient lock-in: 2+ years of health data creates insurmountable switching costs
V. Awards Program
Tiered Awards Structure
Year 1 (Cancer Community) - $28,200 Total:
- Monthly Creative Awards ($100 each): Vibe Designs (Child, Teen, Adult, Senior), AI-Generated Songs, Short Stories
- Monthly Recognition Awards ($500 each, alternating): Warrior of the Month (odd months), Caregiver of the Month (even months)
- Annual Recognition Awards ($5,000 each): Warrior of the Year, Caregiver of the Year
Scaling with Disease Communities: As we add Alzheimer's, Autism, Parkinson's, Long COVID, Aged Care, Obesity, and Type II Diabetes, awards expand proportionally-each new community adds roughly $28.2K/year at current levels with the same recognition categories.
Provider Recognition: Provider of the Year awards honor physicians, healthcare systems, and entities making measurable patient impact.
How Awards Are Funded
Year 1: Funded from ICO proceeds ($28.2K from $875K raise). Establishes recognition culture before enterprise revenue scales.
Years 2+: Funded from enterprise revenue:
- Enterprise subscriptions ($15/patient/month)
- Solo practitioner subscriptions ($1/patient/month)
- Pharma RWE data licensing ($500K-$5M/partner)
- Transaction fees (1%)
Token Appreciation Potential: Awards paid in tokens at current market value. Early recipients who hold tokens may benefit from platform growth, but this is speculative upside-not guaranteed. Award values are denominated in dollars ($100, $500, $5,000) for immediate liquidity.
Revenue Sharing Model: Patients Deserve To Benefit
Traditional healthcare extracts patient data for profit (pharma, hospitals, insurers make billions) but patients get nothing. We flip this model:
- Patients contribute data: Daily vitals, side effects, treatment outcomes create value
- Patients earn tokens: Log vitals = earn tokens. Participate in community = earn tokens. Complete surveys = earn tokens. These are digital assets with real monetary value, not gamification points.
- Patients receive awards: Monthly ($100-$500), Annual ($5,000). Clear, predictable recognition.
- Community-directed research: Tokenized ecosystem funds patient-driven research. Community votes on research priorities.
Revenue sharing: Hospitals pay $15/patient/month for provider access, pharma pays $500K-$5M for RWE data licensing-we share that revenue back with patients through token rewards and awards. Your data generates value; you deserve to benefit.
Award Categories
- Warrior Awards: Recognizing patients battling chronic disease with courage and resilience
- Caregiver Awards: Honoring the dedication of family members and caregivers
- Creative Awards: Celebrating community contributions (Vibe designs, music, stories)
- Provider Awards: Recognizing healthcare professionals delivering exceptional care
All award stories preserved on blockchain-permanent, globally accessible testament to human resilience.
VI. 116 Languages
116 Locales. Automated Expansion.
Every locale available in i18next is now supported in CareHub. We receive automated weekly email notifications when new languages become available and add them to the database immediately. No phased rollout. No waiting. If the translation framework supports it, so do we.
What We Cover
- Major languages: English, Spanish, Mandarin, Arabic, French, German, Portuguese, Japanese, Russian, Hindi, Bengali, Korean, and 100+ more
- RTL support: Arabic, Hebrew, Farsi, Urdu with full right-to-left rendering
- Indigenous languages: Navajo, Cree, Māori, Quechua, and others as i18next adds support
- African languages: Swahili, Zulu, Amharic, Hausa, Yoruba, and 15+ more
Linguistic Equity Saves Lives
Limited English Proficiency patients face 2-3x higher mortality rates. Misunderstood treatment instructions. Medication errors. CareHub serves every patient in their language, not just the profitable demographics.
Speak a Language We Don't Offer?
If your language isn't in our 116 locales, we want to know. Contact research.carehub@gmail.com and we'll research adding it. Our commitment: if it's technically possible, we'll make it happen.
Multilingual Data Monopoly
- Cross-disease progression data in 116 languages-pharmaceutical licensing gold for global clinical trials
- Professional medical validation: Native-speaking healthcare professionals verify terminology accuracy
- Years ahead of competitors: Most apps support 2-5 languages. We support 116. First-mover advantage is permanent.
VII. Leadership
Leadership
David Lennard, Founder-6-year cancer warrior with multiple myeloma, purpose-driven to find solutions to help close the Care Gap. Career marketing strategist with senior executive startup experience and leadership roles at two ASX-listed blue-chip corporations.
Founder Authenticity: Lived Experience + Executive Expertise
David builds CareHub to solve his own survival challenge as a 6-year cancer warrior, creating solutions that work for millions facing similar battles:
- Lived experience: 6 years navigating multiple myeloma-understanding pain points developers miss (2am side effects, caregiver guilt, financial toxicity)
- Community trust: "One of us" builds loyalty focus groups can't replicate
- Product-market fit: Features prioritized by real need-voice tech for speech-impaired, consent tracking, multilingual support
- Marketing advantage: "Cancer warrior building lifeline" resonates deeper than "Silicon Valley disrupts healthcare"
- Legacy commitment: Platform must work for David's survival-quality standards competitors can't match
Senior executive experience (ASX blue-chips + startups) provides operational sophistication. Cancer journey provides mission clarity. This combination attracts patients, ambassadors, enterprise partners, and purpose-driven investors.
Corporate Structure: Delaware Public Benefit Corporation
CareHub incorporates as a Delaware PBC-legally enshrining patient-first mission while enabling venture-scale returns. This is NOT a DAO (vulnerable to whale capture, regulatory risk, mission drift). Three founder tiers align incentives:
| Tier | Investment | Allocation | IPO Value ($25) |
|---|---|---|---|
| Principal Founder | $250,000 | 4% (20M tokens) | $500M |
| Co-Founders (7) | $50,000 each | 2% each (10M tokens) | $250M each |
| Founding Council (100) | $1,000 each | 0.5% total (25K each) | $625K each |
| Total | $700,000 | 18.5% | $2.3B |
Why this structure works:
- Principal Founder ($250K): Reflects 3+ years of 16hr/day development (17,000+ hours). Equivalent agency cost: $500K-$1M+
- Co-Founders ($50K for 2%): $25K per 1% = seed-stage market rate. Classic YC priced at $18K/1%; we're in the fair range
- Founding Council ($1K): Accessible entry for mission-aligned patients/caregivers/HCPs with advisory voting rights (curated, not whale-captured)
B Corp + Tiered Founders = legally mission-locked, transparent governance, 5,000x co-founder returns at IPO. Full founder details →